951127-34-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Acetyl-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a pharmaceutical intermediate for the synthesis of various drugs and other bioactive molecules. Its role in this industry is vital, as it aids in the production of a wide range of pharmaceutical products that cater to different medical needs.
Used in Drug Synthesis:
As a key intermediate in drug synthesis, 3-Acetyl-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester is employed to facilitate the creation of new and existing medications. Its chemical properties make it a suitable candidate for use in the development process, contributing to the advancement of pharmaceutical research and innovation.
Used in Bioactive Molecule Production:
3-Acetyl-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester is also utilized in the production of bioactive molecules, which are essential in various biological and medical applications. Its presence in this process highlights its versatility and importance in the broader field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 951127-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,1,2 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 951127-34:
(8*9)+(7*5)+(6*1)+(5*1)+(4*2)+(3*7)+(2*3)+(1*4)=157
157 % 10 = 7
So 951127-34-7 is a valid CAS Registry Number.
951127-34-7Relevant academic research and scientific papers
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
-
Page/Page column 18, (2008/06/13)
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 36, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
